Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
15,247
datasets available to search
ShareScore release 0.9.0
Dataset results
15,247 results for “Breast cancer”
Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer
ClinicalTrials.gov study NCT00356811. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03197935. IPD Sharing: Not stated. Countries: 13. Publications: 3.
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00093808. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
ClinicalTrials.gov study NCT02734290. IPD Sharing: NO. Countries: 1. Publications: 2.
Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer
ClinicalTrials.gov study NCT04205903. IPD Sharing: NO. Countries: 1. Publications: 1.
Olaparib in Combination With Either Durvalumab, Selumetinib, or Capivasertib or Ceralasertib Alone in Treating Patients With Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03801369. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BC
ClinicalTrials.gov study NCT02771795. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
ClinicalTrials.gov study NCT00834678. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab
ClinicalTrials.gov study NCT04023110. IPD Sharing: NO. Countries: 1. Publications: 1.
Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence
ClinicalTrials.gov study NCT00030823. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer
ClinicalTrials.gov study NCT02776917. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Meta
ClinicalTrials.gov study NCT02203513. IPD Sharing: YES. Countries: 1. Publications: 2.
Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer
ClinicalTrials.gov study NCT04750473. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients
ClinicalTrials.gov study NCT01234402. IPD Sharing: YES. Countries: 2. Publications: 1.
Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer
ClinicalTrials.gov study NCT02520063. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy
ClinicalTrials.gov study NCT04394247. IPD Sharing: NO. Countries: 1. Publications: 1.
Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer
ClinicalTrials.gov study NCT00603408. IPD Sharing: Not stated. Countries: 1. Publications: 16.
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
ClinicalTrials.gov study NCT01740427. IPD Sharing: YES. Countries: 18. Publications: 25.
Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients
ClinicalTrials.gov study NCT07273812. IPD Sharing: YES. Countries: 1. Publications: 5.
Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients
ClinicalTrials.gov study NCT02910219. IPD Sharing: NO. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.